P547 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)

Carl Eriksson,Sara Rundquist,V Lykiardopoulos,Per Karlén,Olof Grip,Charlotte Söderman,Sven Almer,Erik Hertervig,Jenny Gunnarsson,C Malmgren,J. Delin,Hans Strid,Mats Sjöberg,D. Oberg,Daniel Bergemalm,Ruzan Udumyan,Henrik Hjortswang,Jonas Halfvarson

P547 Clinical effectiveness of vedolizumab: Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with ulcerative colitis (SVEAH UC)

2018

Carl Eriksson
Sara Rundquist
V Lykiardopoulos
Per Karlén
Olof Grip
Charlotte Söderman
Sven Almer
Erik Hertervig
Jenny Gunnarsson
C Malmgren
J. Delin
Hans Strid
Mats Sjöberg
D. Oberg
Daniel Bergemalm
Ruzan Udumyan
Henrik Hjortswang
Jonas Halfvarson

Clinical effectiveness of vedolizumab : Interim analysis of the Swedish observational study on vedolizumab assessing effectiveness and healthcare resource utilisation in patients with Crohn's disease (SVEAH CD)

Keywords:

Ulcerative colitis
Physical therapy
Observational study
Interim analysis
Anti-Tumor Necrosis Factor Therapy
Vedolizumab
Irritable bowel syndrome
Quality of life
Inflammatory bowel disease
Medicine
Internal medicine
Intensive care medicine
clinical effectiveness
Health care

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations